			Home About us Contact

Health Claims (health + claim)

Distribution by Scientific Domains

Medical Sciences	70%
Business, Economics, Finance and Accounting	10%

Selected Abstracts

Probiotics and Their Potential Health Claims

NUTRITION REVIEWS, Issue 6 2006
Sylvia Santosa BASc
Many studies have attempted to identify specific positive health effects of probiotics. One of the challenges in generalizing health effects of probiotics is that different strains exert disparate effects on human health. As a result, the efficacy of one strain or species cannot necessarily be inferred from another. The objective of this review is to examine the current scientific literature that could be used as the basis for potential health claims. More specifically, this paper will review existing evidence of different probiotic strains to prevent and treat diarrhea, treat irritable bowel syndrome (IBS), treat inflammatory bowel disease, and prevent colon cancer. The strongest evidence is related to the use of Lactobacillus rhamnosus GG in the prevention and treatment of rotavirus-associated diarrhea. Further examination of the literature also shows promise in the treatment of some forms of IBS with probiotics. Future studies that use consistent supplementation regimes will allow more definitive conclusions to be drawn on the effects of probiotics on IBS, inflammatory bowel disease, and colon cancer. [source]

State-Funded Abortions Versus Deliveries: A Comparison of Outpatient Mental Health Claims Over 4 Years

AMERICAN JOURNAL OF ORTHOPSYCHIATRY, Issue 1 2002
Priscilla K. Coleman PhD
In this record-based study, rates of 1st-time outpatient mental health treatment for 4 years following an abortion or a birth among women receiving medical assistance through the state of California were compared. After controlling for preexisting psychological difficulties, age, months of eligibility, and the number of pregnancies, the rate of care was 17% higher for the abortion group (n = 14,297) in comparison with the birth group (n = 40,122). Within 90 days after the pregnancy, the abortion group had 63% more claims than the birth group, with the percentages equaling 42%, 30%, and 16% for 180 days, 1 year, and 2 years, respectively. Additional comparisons between the abortion and birth groups were conducted on the basis of claims for specific types of disorders and age. [source]

Surrogate endpoints and emerging surrogate endpoints for risk reduction of cardiovascular disease

NUTRITION REVIEWS, Issue 2 2008
Crystal M Rasnake
This article reviews surrogate endpoints and emerging biomarkers that were discussed at the annual "Cardiovascular Biomarkers and Surrogate Endpoints" symposium cosponsored by the US Food and Drug Administration (FDA) and the Montreal Heart Institute. The FDA's Center for Food Safety and Applied Nutrition (CFSAN) uses surrogate endpoints in its scientific review of a substance/disease relationship for a health claim. CFSAN currently recognizes three validated surrogate endpoints: blood pressure, blood total cholesterol, and blood low-density lipoprotein (LDL) concentration in its review of a health claim for cardiovascular disease (CVD). Numerous potential surrogate endpoints of CVD are being evaluated as the pathophysiology of heart disease is becoming better understood. However, these emerging biomarkers need to be validated as surrogate endpoints before they are used by CFSAN in the evaluation of a CVD health claim. [source]

Chromium Picolinate Intake and Risk of Type 2 Diabetes: An Evidence-Based Review by the United States Food and Drug Administration

NUTRITION REVIEWS, Issue 8 2006
Paula R. Trumbo PhD
The labeling of both health claims that meet significant scientific agreement (SSA) and qualified health claims on conventional foods and dietary supplements requires pre-market approval by the US Food and Drug Administration (FDA). Approval by the FDA involves, in part, a thorough review of the scientific evidence to support an SSA or a qualified health claim. This article discusses FDA's evidence-based review of the scientific evidence on the role of chromium picolinate supplements in reducing the risk of type 2 diabetes. Based on this evidence-based review, FDA issued a letter of enforcement discretion for one qualified health claim on chromium picolinate and risk of insulin resistance, a surrogate endpoint for type 2 diabetes. The agency concluded that the relationship between chromium picolinate intake and insulin resistance is highly uncertain. SUMMARY In summary (Table 1), there was one intervention study that showed a beneficial effect of chromium picolinate intake on risk of insulin resistance. One other intervention study that provided chromium chloride showed no beneficial effect on insulin resistance. None of the five intervention studies showed a statistically significant beneficial effect of chromium picolinate on FBS and/or OGTT. Furthermore, none of the 10 intervention studies using other forms of chromium showed a beneficial effect of on FBS or OGTT in individuals with normal glucose tolerance. Based on FDA's evidence-based review, the agency concluded that there is very limited credible evidence for a qualified health claim for chromium picolinate and reduced risk of insulin resistance, and therefore reduced risk of type 2 diabetes. The findings of Cefalu et al. have not been replicated, and replication of scientific findings is important to substantiate results. For these reasons, FDA concluded that the existence of a relationship between chromium picolinate intake and reduced risk of either insulin resistance or type 2 diabetes is highly uncertain. On August 25, 2005, FDA issued a letter of enforcement discretion for the labeling of dietary supplements with the following qualified health claim: "One small study suggests that chromium picolinate may reduce the risk of insulin resistance, and therefore possibly may reduce the risk of type 2 diabetes. FDA concludes, however, that the existence of such a relationship between chromium picolinate and either insulin resistance or type 2 diabetes is highly uncertain." The agency concluded that there was no credible evidence to suggest that chromium picolinate intake may reduce the risk of elevated blood glucose levels. [source]

Processed animal products with emphasis on polyunsaturated fatty acid content

EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY, Issue 5 2009
Sabine Sampels
Abstract The fat composition of processed fish and meat varies due to the source of the animal diet and to the fats used during processing. The aim of this study was to analyse the fatty acid profiles in some commonly available fish and meat fast foods. Variation between similar products from different brands indicated the use of different fat sources during processing. Especially in fish products, a high variation was found in the n -6/n -3 ratio, being up to more than 400-fold higher than in plain fish, which might be of special concern in the evaluation of diet-related health claims. Many products showed considerable differences compared to those included in the official database used for calculation of dietary intake. This leads to the conclusion that the fat sources used during processing of fast food should be reported and available to the consumers. Interdisciplinary dialogue between all sectors involved in food production, processing and health care is proposed to evaluate optimal development of fast foods with nutritionally favourable fat composition. [source]

Firm, market, and regulatory factors influencing innovation and commercialization in Canada's functional food and nutraceutical sector

AGRIBUSINESS : AN INTERNATIONAL JOURNAL, Issue 2 2008
Deepananda Herath
Factors influencing the development and commercialization of functional food and nutraceutical (FFN) products are explored. Count data models are developed to relate firm, market, and regulatory covariates to the number of FFN product lines firms have under development, on the market, and in total. Canadian firm-level innovation data were taken from Statistics Canada (2003) Functional Food and Nutraceutical Survey. Firms involved in product development/scale-up had more product lines in total and on the market. Firms with a strong and positive perception of the impact of regulatory reform related to generic health claims and harmonization of Canadian regulations with U.S. regulations had fewer product lines in total and on the market. Firms with more positive perceptions of the business impact of structure and function health claims had more product lines on the market. One implication of the study is the importance of developing policies and reforming regulations which better enable use of generic health claims on FFN products. Further, policies which better enable or foster development/scale-up of product lines would increase the Canadian FFN sector's ability to develop new products. [EconLit: O130, L500, Q180]. © 2008 Wiley Periodicals, Inc. [source]

Internet Survey of Nutrition Claim Knowledge

JOURNAL OF FOOD SCIENCE EDUCATION, Issue 2 2005
Mary E. Camire
ABSTRACT: Consumer interest in healthy foods has spurred approval of several health claims for foods and dietary supplements. Although undergraduate and graduate food science curricula address food laws and regulations, nutrition claims may not be fully addressed. We posted a survey on the Internet for 2 mo for food industry professionals and others interested in taking the survey to assess their understanding of laws and regulations pertaining to nutrition labeling for foods and dietary supplements. The purpose of this survey was to measure knowledge in this area so that our university and others could reevaluate their curricula to provide student and lifelong learners with appropriate information about this important topic. Respondents were asked to indicate whether displayed claims were health claims, structure-function claims, or not approved for use on food labels. Respondents (N= 136) indicated that they gained information about nutrition claims from many sources. Although respondents correctly identified approved health claims and claims that are not approved for foods, some confusion about nutrition claims may exist because not all respondents correctly identified claims in the appropriate category. Issues in educating food scientists include keeping food labeling information current and defining complex topics such as structure-function claims. The findings of this pilot study have been used to incorporate lectures about health claims in courses in addition to the food law class at the Univ. of Maine. [source]

ASSESSING CONSUMER EXPECTATIONS FOR FOOD BARS BY CONJOINT ANALYSIS

JOURNAL OF SENSORY STUDIES, Issue 6 2009
K. MAHANNA
ABSTRACT Food bars, which include meal replacement, protein, granola and cereal bars, have rapidly increased in sales with current estimation of above $3.2 billion. Despite such rapid growth in the market, research on consumer expectations for these products is still lacking. Conjoint analysis was used to probe the effect of different elements of food bar products on purchase intent, including types of bar, ingredients, macro-nutrients, health claims, calories and sensory characteristics. Overall, consumers wanted a food bar to be less than 150 kcal, made with whole grains and higher in protein. Consumers divided into four mind-set segments were characterized as "Label Readers" (n = 213), "Calorie Health Nuts" (n = 90), "Flavor Energy Seekers" (n = 79) and "Chocolate Lovers" (n = 44). Sensory characteristics and types of bar categories were not important to consumers, although calorie elements played the largest role in motivating purchase intent for food bars. PRACTICAL APPLICATIONS The results found from this research help to guide new product development in the food bar market by identifying the desires of specific consumer segments. Consumers were interested in food bar products with lower calorie content, which supports the idea that food bars are more typically consumed as a snack than a meal replacement. Half of the sample consumers tested belonged to the "Label Readers" segment. These consumers are interested in a healthful food bar product high in fiber. Development of a bar that is considered healthful would appeal not only to the "Label Readers" segment, but also to the "Calorie Health Nuts" segment. When developing a food bar product, the labeled bar type or sensory claims are not important to consumers. Consumers are more interested in the ingredients and caloric content of the food bar. [source]

Evidence based nutrition and health claims on foods: a renaissance?

MATERNAL & CHILD NUTRITION, Issue 2 2006
Peter Aggett Editor
[source]

NEWS FROM EU RESEARCH: BaSeFood: sustainable exploitation of bioactive components from the Black Sea Area traditional foods

NUTRITION BULLETIN, Issue 3 2010
F. D'Antuono
Summary The Sustainable exploitation of bioactive components from the Black Sea Area traditional foods (BaSeFood) is a 3-year collaborative research programme, funded by the 7th Framework Programme, launched on the 1st of April 2009. The project, which is coordinated by Dr Filippo D'Antuono (University of Bologna), consists of a research consortium of 13 partners, namely Italy (two), the United Kingdom, Greece, Portugal, Serbia and six Black Sea area countries: Russian Federation, Ukraine (two), Romania, Bulgaria, Turkey and Georgia. BaSeFood will contribute scientifically by studying the bioactive compounds within traditional foods of the Black Sea area using rigorous analytical and biological assays. The vast array of characteristics of traditional foods will be considered, as well as any associated consumer-perceived benefits, related to health claims, so that they can be properly understood by the consumer and exploited by food processors to produce more healthy traditional foods. [source]

An update on nutrition and health claims

NUTRITION BULLETIN, Issue 4 2008
B. Aisbitt
[source]

The scientific substantiation of health claims: recent developments in the European Union

NUTRITION BULLETIN, Issue 2 2003
David P. Richardson
First page of article [source]

Chromium Picolinate Intake and Risk of Type 2 Diabetes: An Evidence-Based Review by the United States Food and Drug Administration

Probiotics and Their Potential Health Claims

Probiotics: Considerations for Human Health

NUTRITION REVIEWS, Issue 3 2003
Mary Ellen Sanders PhD
Evidence for the role of probiotics in maintenance of health or prevention of disease is mounting and is supported in some cases by blinded, placebo-controlled human trials. Today, in an era of antibiotic-resistant pathogens and other looming microbial threats, the value of prevention of infection is recognized. Probiotics may play an important role in helping the body protect itself from infection, especially along the colonized mucosal surfaces of the gastrointestinal tract. Probiotic products are available in many different forms worldwide, including pills, powders, foods, and infant formula. In some cases, general health claims are made that cannot be substantiated for the specific strains and levels being used and consumers must therefore beware. [source]

Current International Approaches to Food Claims

NUTRITION REVIEWS, Issue 12 2000
No-Seong Kwak Ph.D.
The market for functional foods is rapidly increasing. It is necessary to establish a legal framework for these foods. This has proved difficult in a number of countries. The control through health claims is generally accepted as the most appropriate measure. Activity in this area has been developing both at the national and international levels. However, the regulations and proposals from a number of national authorities and other nongovernmental sectors are varied and difficult to reconcile. This paper examines the range of health claim controls being used in the food area. They are considered in detail so as to establish a better understanding of the claims. In this paper, the claims have been classified into six categories: nutrient content claims, comparative claims, nutrient function claims, claims related to dietary guidelines or healthy diets, enhanced function claims, and reduction of disease risk claims. Of these, the latter four claims are considered to have significant implications for functional foods. [source]

Policy Development for Novel Foods: Issues and Challenges for Functional Food

CANADIAN JOURNAL OF AGRICULTURAL ECONOMICS, Issue 4 2002
Michele Veeman
Challenges in policy development for novel foods arise from information asymmetry associated with these credence goods. Policy development reflects pressures by firms and investors to apply health claims in marketing functional food, nutraceuticals and natural health products, which are growing market segments, relative to mature food markets. However, the wordings on health claims are often misinterpreted by consumers. Despite tendencies for some convergence in approaches to health claim policies, policy differs internationally. Related issues considered include factors influencing consumer preferences for these products and uncertainties in the markets for them. [source]